EGFR and glioblastoma: Other mechanosensors promoting EMT via several pathways such as transient receptor potential melastatin 7 (TRPM7)/SOX4 in breast cancer [273], CXCR4/ubiquitin domain containing 1 (UBTD1)/YAP in hepatoma [141] and EGFR in glioblastoma [274] have been reported.